An HIV vaccine: How and when?

Bulletin of the World Health Organization

Volumn 79, Issue 12, 2001, Pages 1133-1137

  Esparza, José ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Acquired immunodeficiency syndrome prevention and control; AIDS vaccines immunology; Clinical trials; HIV infections prevention and control; HIV genetics; Models, Animal (source: MeSH)

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

DISEASE CONTROL; HUMAN IMMUNODEFICIENCY VIRUS; VACCINATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFICACY; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; INFECTION CONTROL; LONG TERM CARE; MEDICAL ETHICS; PROPHYLAXIS; REVIEW; VACCINATION;

AIDS VACCINES; ANIMALS; CLINICAL TRIALS; ETHICS; EVIDENCE-BASED MEDICINE; HIV; HIV INFECTIONS; HUMANS; MODELS, ANIMAL; RESEARCH; WORLD HEALTH ORGANIZATION;

EID: 0035698345     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. The global impact of HIV/AIDS
2. Accelerating the development and future availability of HIV-1 vaccines: Why, when, where, and how?
3. Current issues in HIV vaccine development
4. HIV vaccine research: From basic science to human trials
5. Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1. Report from a meeting of the WHO-UNAIDS Vaccine Advisory Committee, Geneva, 21-23 February 2000
6. Epidemiological considerations in planning HIV preventive vaccine trials
7. Preparing for HIV vaccine efficacy trials in developing countries
8. Declaration of commitment on HIV/AIDS
9. Challenges and opportunities for development of an AIDS vaccine
10. Ethical considerations in international HIV vaccine trials: Summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS)
11. Future access to HIV vaccines. Report from a WHO-UNAIDS consultation, Geneva, 2-3 October 2000